These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 8097975
1. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ. Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975 [Abstract] [Full Text] [Related]
2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T, Lehmann M, Flye MW. Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332 [Abstract] [Full Text] [Related]
3. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance. Arima T, Goss JA, Walp LA, Flye MW. Surgery; 1995 Aug 27; 118(2):265-72; discussion 272-3. PubMed ID: 7638743 [Abstract] [Full Text] [Related]
4. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Darby CR, Morris PJ, Wood KJ. Transplantation; 1992 Sep 27; 54(3):483-90. PubMed ID: 1384184 [Abstract] [Full Text] [Related]
5. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations. Qi Z, Riesbeck K, Ostraat O, Tufveson G, Ekberg H. Transpl Immunol; 1997 Sep 27; 5(3):204-11. PubMed ID: 9402687 [Abstract] [Full Text] [Related]
6. Prediction of graft prolongation by mixed lymphocyte culture following anti-CD4 monoclonal antibody treatment among different donor-recipient combinations. Hamano K, Ito H, Shirasawa B, Gohra H, Katoh T, Fujimura Y, Esato K. Surg Today; 1999 Sep 27; 29(9):868-73. PubMed ID: 10489127 [Abstract] [Full Text] [Related]
7. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA, Seydel KB, Flavin TF, Wu AP, Kong CC, Hoyt EG, Fujimoto N, Billingham ME, Starnes VA, Fathman CG. Transplantation; 1990 Sep 27; 50(3):366-73. PubMed ID: 1976282 [Abstract] [Full Text] [Related]
8. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Transplantation; 1992 Sep 27; 54(3):475-83. PubMed ID: 1384183 [Abstract] [Full Text] [Related]
9. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Hamano K, Rawsthorne MA, Bushell AR, Morris PJ, Wood KJ. Transplantation; 1996 Sep 27; 62(6):856-60. PubMed ID: 8824489 [Abstract] [Full Text] [Related]
10. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. Chen W, Ford MS, Young KJ, Cybulsky MI, Zhang L. J Immunol; 2003 Feb 15; 170(4):1846-53. PubMed ID: 12574350 [Abstract] [Full Text] [Related]
11. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K, Arima T, Lehmann M, Flye MW. Surgery; 1997 Aug 15; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [Abstract] [Full Text] [Related]
12. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Transplantation; 1994 Sep 15; 58(5):576-84. PubMed ID: 7522364 [Abstract] [Full Text] [Related]
13. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK, Shelby J, Eichwald EJ. Transplantation; 1992 Apr 15; 53(4):849-57. PubMed ID: 1533070 [Abstract] [Full Text] [Related]
14. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Sayegh MH, Sablinski T, Tanaka K, Kut JP, Kwok CA, Tilney NL, Kupiec-Weglinski JW, Milford EL. Transplantation; 1991 Feb 15; 51(2):296-9. PubMed ID: 1704648 [Abstract] [Full Text] [Related]
15. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen. Niimi M, Witzke O, Bushell A, Hara M, Morris PJ, Wood KJ. Transplantation; 2000 Nov 27; 70(10):1524-8. PubMed ID: 11118100 [Abstract] [Full Text] [Related]
16. Anti-CD4 monoclonal antibody treatment combined with total lymphoid irradiation and cyclosporin A in hamster-to-rat cardiac transplantation. Analysis of lymphocyte subsets and anti-donor xenoantibodies. Steinbrüchel DA, Madsen HH, Lillevang S, Nielsen B, Kemp E. Transpl Immunol; 1993 Nov 27; 1(3):209-16. PubMed ID: 7915954 [Abstract] [Full Text] [Related]
17. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA. J Heart Lung Transplant; 2005 Sep 27; 24(9):1410-4. PubMed ID: 16143264 [Abstract] [Full Text] [Related]
18. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM. Transplantation; 1997 Apr 27; 63(8):1109-17. PubMed ID: 9133472 [Abstract] [Full Text] [Related]
19. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW. Surgery; 2000 Aug 27; 128(2):206-12. PubMed ID: 10922993 [Abstract] [Full Text] [Related]
20. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. Niimi M, Hara M, Witzke O, Morris PJ, Wood KJ. Transplantation; 1998 Dec 27; 66(12):1786-92. PubMed ID: 9884277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]